iiinova — where your digital self keeps evolving

Reposted by Michelle Meyer

BWJones @bwjones.bsky.social · 25/09/2026

Science peeps: Looks like SciENcv updated the digital certificate used to sign Biosketch and Current & Pending documents without notification. The old certificate expires Saturday, September 26, 2026. SciENcv docs before that date may fail validation in eRA Commons delaying or blocking submission.

77472

Michelle Meyer @michellemeyer.bsky.social · 06/07/2026

🚨POSTDOC HIRING: Our lab in the Dept. of Bioethics & Decision Sciences in Geisinger's College of Health Sciences is hiring a Postdoct in the Behavioral Science of Health-Related Beliefs, Judgment & Decision-Making. Start date is asap. Can be remote from anywhere in U.S. tinyurl.com/MeyerChabris...

084

Michelle Meyer @michellemeyer.bsky.social · 21/05/2026

Feel free to reach out to me about that specific scenario, especially if you're in the AI ethics lane.

000

Michelle Meyer @michellemeyer.bsky.social · 21/05/2026

geisinger.wd5.myworkdayjobs.com/GeisingerExt... We’ll be hiring multiple roles reporting to the Lead Data Scientist. For the right person—someone excited to contribute to externally-funded research on AI/AI ethics—there may be an opportunity for split time w/ research, potentially in a faculty role.

geisinger.wd5.myworkdayjobs.com

Tech Lead Data Scientist, AI Evaluation & Monitoring

Location: Work from home (Pennsylvania) Shift: Days (United States of America) Scheduled Weekly Hours: 40 Worker Type: Regular Exemption Status: Yes Job Summary: The Tech Lead Data Scientist, AI Evalu...

100

Michelle Meyer @michellemeyer.bsky.social · 21/05/2026

Geisinger is hiring a Lead Data Scientist responsible for evaluating the AI deployed here and monitoring it over time. Among the teams this role will work closely with is the multidisciplinary AI governance team (including me). This is a critical role—please circulate widely!

110

Michelle Meyer @michellemeyer.bsky.social · 18/05/2026

Today I'm thrilled to welcome Paul Han to the Department of Bioethics and Decision Sciences in the @geisingercollege.bsky.social at @geisinger.bsky.social. A recent Fulbright Scholar who studies medical decision-making, uncertainty, and risk communication, Dr. Han joins us from NCI/NIH.

031

Michelle Meyer @michellemeyer.bsky.social · 08/05/2026

Maybe they will issue (apparently reduced) NOFOs though RP1s and reserve R01s/R21s for investigator-initiated research?

000

Michelle Meyer @michellemeyer.bsky.social · 07/05/2026

Lesson two: the benefit of being a bit slow getting a paper out is that you can track sustainability of effects over many years!

110

Michelle Meyer @michellemeyer.bsky.social · 07/05/2026

In an exploratory analysis, we found no difference in portal engagement over the ensuing four years between those who were nudged to enroll vs. those in the control condition who enrolled on their own, i.e., nudged enrollees became typical portal users.

100

Michelle Meyer @michellemeyer.bsky.social · 07/05/2026

There was no difference between the two nudge emails, which contained action buttons that were either more (Get Started With [MyChart]) or less (View my Lab Results) transparent about the brief registration steps necessary to activate the portal before accessing results.

100

Michelle Meyer @michellemeyer.bsky.social · 07/05/2026

Participants who received either email were about 3 times more likely to active their patient portal within one week. Lesson one: it's effective to encourage people to sign up for a service when doing so has an immediate pay off for them as opposed to when it's convenient for you.

110

Michelle Meyer @michellemeyer.bsky.social · 07/05/2026

🚨New paper from our Behavioral Insights Team🚨: we randomized patients without activated patient portals who had new lab results to receive one of two emails emphasizing a key portal feature—immediate access to results—or to no contact beyond usual system efforts to encourage enrollment.

142

Michelle Meyer @michellemeyer.bsky.social · 30/04/2026

Importantly, Sage Bionetworks' eConsent framework doesn't just digitize paper consent. It presents one concisely stated concept per screen, uses icons to visually reinforces concepts, allows info-seekers to “learn more,” & asks formative questions to reinforce learning.

110

Michelle Meyer @michellemeyer.bsky.social · 30/04/2026

Limitations include some imbalance in a few demographics between arms and the fact that this study compares only one application of the eConsent to one standard consent process.

110

Michelle Meyer @michellemeyer.bsky.social · 30/04/2026

Using scores on a 10-item comprehension quiz as our primary outcome, we found the eConsent was noninferior (and, in an exploratory analysis using a conservative alpha of p < 0.005, superior) to a traditional consent process for biobank enrollment.

110

Michelle Meyer @michellemeyer.bsky.social · 30/04/2026

🚨New paper! eConsent can promote cost-effectiveness & equity in research, but how does it compare to traditional consent w/r/t informedness? In this RCT, we tested the Sage Bionetworks eConsent developed by @megdoerr.bsky.social & @wilbanks.bsky.social, used by, eg NIH All of Us & Apple ResearchKit.

Screenshots of the eConsent, showing different user design principles.

195

Michelle Meyer @michellemeyer.bsky.social · 25/10/2025

I missed the llama AND the rooster?! I want a Portland refund

040

Reposted by Michelle Meyer

Scott Myers @smyers20.bsky.social · 27/09/2025

New PubPeer comment on "Efficacy of oral folinic acid supplementation in children with autism spectrum disorder: a randomized double-blind, placebo-controlled trial" (Panda et al, 2024). Concerns about significant errors. #folinicacid #leucovorin, #autism pubpeer.com/publications...

pubpeer.com

PubPeer - Efficacy of oral folinic acid supplementation in children wi...

There are comments on PubPeer for publication: Efficacy of oral folinic acid supplementation in children with autism spectrum disorder: a randomized double-blind, placebo-controlled trial (2024)

1139

Michelle Meyer @michellemeyer.bsky.social · 10/09/2025

I’m excited to participate in Mass General’s 5th annual Conference on Precision Psychiatry, which will be held virtually on Sept. 25–26. It’s free for trainees and learners and there is a discount code below for everyone else.

010

Reposted by Michelle Meyer

Brian Nosek @briannosek.bsky.social · 04/06/2025

A huge development for normalization and support of the scientific sleuth community as an important component of a healthy, high integrity research system.

0175

Reposted by Michelle Meyer

David Lazer @davidlazer.bsky.social · 15/05/2025

If you are at #WebSci2025, join our "Beyond APIs: Collecting Web Data for Research using the National Internet Observatory" - a tutorial that addresses the critical challenges of web data collection in the post-API era. national-internet-observatory.github.io/beyondapi_websci25/

12110

Reposted by Michelle Meyer

Christopher Chabris @cfchabris.bsky.social · 14/05/2025

At Geisinger we have created a new team to conduct and publish rigorous evaluations of important health system initiatives, programs, and interventions. I'm one of the faculty co-directors of this group and I'm happy to say we have two new positions open! (1/2)

173

Michelle Meyer @michellemeyer.bsky.social · 10/05/2025

And you’d try to get the meeting started but with every straggler you’d be interrupted with “Dan” <recorded in exasperated tone> “is joining the call.” (JK I’m sure you never straggled.)

120

Michelle Meyer @michellemeyer.bsky.social · 06/05/2025

Location: Danville, PA or (for exceptional candidates) any U.S. location. Watch for more jobs in the coming days as we grow our Behavioral Insights and Program Evaluation teams! (2/2)

000

Michelle Meyer @michellemeyer.bsky.social · 06/05/2025

We’re hiring! tinyurl.com/GeisingerBIT Geisinger’s Behavioral Insights Team is looking for a new Staff Scientist. We conduct large pragmatic trials of behavioral science-informed interventions to improve health outcomes, with work published/forthcoming in Nature Hum Behav, PNAS, JAMA Netw Open 1/2

tinyurl.com

173

Michelle Meyer @michellemeyer.bsky.social · 20/03/2025

Reviewer 2 used an LLM to generate their review of our manuscript—except for the part where they asked for several irrelevant papers, all mysteriously authored by the same person, to be cited. Thank you, Reviewer 1, whoever you are. Not all heroes wear capes.

I am unconvinced that the three additional citations, all to [redacted], add to the paper. Although I fully understand the authors’ decision to include them given the other reviewer’s suggestions, I would like to voice my firm support if they prefer not to include them in the final version.

1222

Michelle Meyer @michellemeyer.bsky.social · 28/02/2025

We are HIRING a clinical ethicist to join the Department of Bioethics and Decision Sciences in the Geisinger College of Health Sciences! There is potential for advancement into a leadership role in the future for a candidate with preferred qualifications. Please share widely! tinyurl.com/4mu4cv2c

078

Reposted by Michelle Meyer

Josh Gerstein @joshgerstein.bsky.social · 10/02/2025

BREAKING: 22 states sue NIH over Trump administration's new 15% cap on overhead for federal research grants. Suit filed federal court in Boston contends lifesaving research 'will grind to a halt' under the policy. Doc: storage.courtlistener.com/recap/gov.us...

storage.courtlistener.com

6133391140

Reposted by Michelle Meyer

Paul Hufe @paulhufe.net · 28/11/2024

🔊Next conference of the European Social Science Genetics Network (ESSGN) in Bristol, 22-23 May. ✅Keynote by @michellemeyer.bsky.social ✅Panel on the current frontier of MR w/ George Davey-Smith (Bristol), Dalton Conley (Princeton), and Alice Carter (Novo-Nordisk). essgn.org/essgn-confer...

essgn.org

ESSGN Conference IV

Bristol, May 22-23, 2025 CALL FOR PAPERS We are pleased to announce the 4th conference of the European Social Science Genetics Network. This conference aims to improve our understanding of how gene…

23726

Michelle Meyer @michellemeyer.bsky.social · 23/11/2024

Great postdoc opportunity (work from anywhere in the US) in quantitative decision sciences (plus great coverage of this weekend’s @sjdm-tweets.bsky.social conference #FOMO) 👇

060

Reposted by Michelle Meyer

Felipe A. Araujo @felipeaaraujo.bsky.social · 23/11/2024

I'm thrilled that our paper on base-rate neglect (BRN) and on-the-job experience (w/ @cfchabris.bsky.social and @michellemeyer.bsky.social) was just accepted at Management Science! TLDR: on-the-job experience with base-rate type problems mitigates, but does not eliminate, base-rate neglect. 1/7

5347

Michelle Meyer @michellemeyer.bsky.social · 15/07/2024

Thrilled to welcome 3 new faculty members to Geisinger's Department of Bioethics & Decision Sciences: Stephanie Kraft, @byrdnick.com & @katesaylor.bsky.social. Looking forward to seeing them continue their great work. You can read more about the department here: www.geisinger.edu/gchs/researc....

Stephanie Kraft, JD, Assistant Professor
Geisinger Department of Bioethics and Decision Sciences (as of July 15, 2024)

Education:
-- BA, Economics, Stanford
-- JD, University of California Law San Francisco (formerly UC Hastings) (concentration in law & health sciences)
-- Postdoctoral Fellow, Center for Integration of Research on Genetics and Ethics, Stanford Center for Biomedical Ethics, Stanford University School of Medicine

Previously:
-- Assistant Professor, Department of Pediatrics (Division of Bioethics & -- Palliative Care), U. Washington SOM
-- Director of Research, Treuman Katz Center for Pediatric Bioethics & Palliative Care, Seattle Children’s Research Inst.
-- NHGRI K01 awardee on respect and trust in research

Expertise and Research Focus:
-- Ethical, legal, and social implications of genomics
-- Research ethics/ELSI of the Learning Health System
-- Ethics and equity in the implementation of emerging health technologies

Nick Byrd, PhD, Assistant Professor
Geisinger Department of Bioethics and Decision Sciences (as of July 22, 2024)

Education:
-- B.A., Philosophy, Palm Beach Atlantic University
-- M.A., Philosophy, University of Colorado at Boulder
-- Ph.D., Philosophy, Florida State University (most coursework towards a second PhD in Psychology)
-- Intelligence Community Postdoc., Carnegie Mellon University & Stevens Institute of Technology

Previously, Stevens Institute of Technology:
-- Assistant Professor of Philosophy
-- Affiliate Faculty, Institute for Artificial Intelligence
-- Affiliate Faculty, Quantitative Social Science

Expertise and Research Focus:
-- Quantitatively tracing thoughts (transcripts or recordings)
-- Improving decisions (with interventions, nudges, AI)
-- How better decisions benefit education, health, medicine

Kate Saylor, MS, PhD, Assistant Professor
Geisinger Department of Bioethics and Decision Sciences (as of September 2, 2024)

Education:
-- BA, Biology/Neurobiology, Macalester College
-- MS, Neuroscience, Oregon Health & Sciences University
-- PhD, Public Policy, UNC Chapel Hill
-- Postdoctoral Fellow in the ELSI of Genetics and Genomics, Penn Med. Dept. of Medical Ethics & Health Policy

Previously, NIH:
-- NIH Presidential Management Fellow
-- Health Policy Analyst, NHGRI
-- Special Assistant to the Associate Director for Science Policy, Office of the Director

Expertise and research focus:
-- Normative analysis of fairness and equity in cost-effectiveness analysis and healthcare allocation
-- Cost-effectiveness of medical interventions (e.g., BRCA1/2 genetic testing) using simulation modeling
-- Impact of biased data on the quality of evidence across patient populations

0161

Michelle Meyer @michellemeyer.bsky.social · 05/04/2024

Do I have thoughts about peer review? <cracks knuckles> <takes deep breath> <clears calendar for the day>

150

Reposted by Michelle Meyer

Brian Nosek @briannosek.bsky.social · 27/03/2024

Oh my. Danny was an inspiration to a generation of social-behavioral scientists and transformed our understanding of decision-making. I can no longer answer the question "who is the most important living psychologist?" with any confidence. www.washingtonpost.com/obituaries/2...

washingtonpost.com

Daniel Kahneman, Nobel-winning economist, dies at 90

He found that people rely on shortcuts that often lead them to make wrongheaded decisions that go against their own best interest.

35819

Michelle Meyer @michellemeyer.bsky.social · 11/03/2024

I also disagree with IRB review of any survey instrument, since all surveys are exempt one way or another—unless the researchers are relying on exemption 2(ii), which depends on the researcher’s claim that survey responses are not sensitive (I’m happy with the IRB vetting that claim independently).

010

Michelle Meyer @michellemeyer.bsky.social · 11/03/2024

Of course incomplete disclosure is a nebulous concept since one can never disclose all details of a study. I hope the premise isn’t that randomization fits (2). But IMO disclosure isn’t compelled by (1) either, & the fact that it’s called out by some IRBs might indeed reflect an AB effect of sorts.

010

Michelle Meyer @michellemeyer.bsky.social · 11/03/2024

Oh dear. I disagree strongly, but this is not unheard of (& alas I don’t know of a resource arguing the negative). For instance, Penn’s IRB views this as incomplete disclosure (which is at least conceptually coherent, unlike deeming it deception) & requires debriefing irb.upenn.edu/homepage/soc...

010

Reposted by Michelle Meyer

Brendan Nyhan @brendannyhan.bsky.social · 16/11/2023

NEW: Open Letter on the Need for Preregistration Transparency in Peer Review docs.google.com/document/d/1... To work as intended, preregistration needs to be part of peer review process. We make commitments to doing so as authors, editors, & reviewers. Please sign and share widely with colleagues!

43525

Michelle Meyer @michellemeyer.bsky.social · 16/11/2023

Can we add “as reviewers, we will not complain that a study was not preregistered when the prereg link was dutifully included right there, in the manuscript itself, for all to see” and “as editors, we will confirm reviewer claims about lack of preregistration are not obviously false”? #stillbitter

070

Michelle Meyer @michellemeyer.bsky.social · 09/11/2023

‼️We’re hiring for several research positions at the intersection of behavioral science & health, spanning lab studies, big data studies, & field experiments: ✔️Predoctoral fellow (starting asap) ✔️Postdoctoral fellow (starting asap) ✔️Faculty (open rank; timing flexible) Ads: tinyurl.com/BehSciJobs

021

Michelle Meyer @michellemeyer.bsky.social · 11/10/2023

Harvard is asking for all counts against it to be dismissed for failing to state a claim upon which relief can be granted—except for her Title IX claim (they will of course seek summary judgment on that count after discovery, if it gets that far). Data Colada answer due 11/8.

010